These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17165260)
1. [Fluoroquinolones and therapy of bacterial meningitis]. Padeĭskaia EN Antibiot Khimioter; 2006; 51(3-4):53-64. PubMed ID: 17165260 [No Abstract] [Full Text] [Related]
2. Fluoroquinolone use in children. Sabharwal V; Marchant CD Pediatr Infect Dis J; 2006 Mar; 25(3):257-8. PubMed ID: 16511391 [No Abstract] [Full Text] [Related]
3. Bacterial and fungal meningitis and antimicrobial susceptibility pattern in Tikur Anbessa University Hospital, Addis Ababa, Ethiopia. Mengistu M; Asrat D; Woldeamanuel Y; Mengistu G Ethiop Med J; 2011 Oct; 49(4):349-59. PubMed ID: 23409400 [TBL] [Abstract][Full Text] [Related]
4. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies. Chong Y; Yakushiji H; Ito Y; Kamimura T Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723 [TBL] [Abstract][Full Text] [Related]
5. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections. Yoo BK; Triller DM; Yong CS; Lodise TP Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of BMY 45243, a new 5-amino-naphthyridone derivative. Bouzard D; Di Cesare P; Hoffmann P; Fung-Tomc J; Kessler R Drugs Exp Clin Res; 1992; 18(7):291-4. PubMed ID: 1338310 [TBL] [Abstract][Full Text] [Related]
8. Aetiological spectrum and antibiotic susceptibility pattern of bacterial meningitis in infants and children in Hangzhou, China. Mao FF; Wang J; Li JP; Yu XF Acta Paediatr; 2005 Aug; 94(8):1162-3. PubMed ID: 16188869 [No Abstract] [Full Text] [Related]
9. Fluoroquinolones in the management of community-acquired pneumonia in primary care. Wispelwey B; Schafer KR Expert Rev Anti Infect Ther; 2010 Nov; 8(11):1259-71. PubMed ID: 21073291 [TBL] [Abstract][Full Text] [Related]
12. Role of gemifloxacin in the management of community-acquired lower respiratory tract infections. Blondeau JM; Tillotson G Int J Antimicrob Agents; 2008 Apr; 31(4):299-306. PubMed ID: 18276120 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infections. Wicha SG; Haak T; Zink K; Kees F; Kloft C; Kees MG J Clin Pharmacol; 2015 Jun; 55(6):639-46. PubMed ID: 25600294 [TBL] [Abstract][Full Text] [Related]
14. The choice of antibacterial drugs. Med Lett Drugs Ther; 1994 Jun; 36(925):53-60. PubMed ID: 8202025 [No Abstract] [Full Text] [Related]
15. A comparison of neonatal Gram-negative rod and Gram-positive cocci meningitis. Smith PB; Cotten CM; Garges HP; Tiffany KF; Lenfestey RW; Moody MA; Li JS; Benjamin DK J Perinatol; 2006 Feb; 26(2):111-4. PubMed ID: 16435007 [TBL] [Abstract][Full Text] [Related]
16. Drug company sued over research trial in Nigeria. Ahmad K Lancet; 2001 Sep; 358(9284):815. PubMed ID: 11564494 [No Abstract] [Full Text] [Related]
17. Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review). Perletti G; Skerk V; Magri V; Markotic A; Mazzoli S; Parnham MJ; Wagenlehner FM; Naber KG Mol Med Rep; 2011; 4(6):1035-44. PubMed ID: 21874250 [TBL] [Abstract][Full Text] [Related]
18. Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis. Jivcu C; Gotfried M Int J Chron Obstruct Pulmon Dis; 2009; 4():291-300. PubMed ID: 19684863 [TBL] [Abstract][Full Text] [Related]
19. An updated approach to healthcare-associated meningitis. Bardak-Ozcem S; Sipahi OR Expert Rev Anti Infect Ther; 2014 Mar; 12(3):333-42. PubMed ID: 24512210 [TBL] [Abstract][Full Text] [Related]
20. [Trovafloxacin]. Azanza JR; Ollero D; Sádaba B; García Quetglas E Rev Med Univ Navarra; 1999; 43(1):45-57. PubMed ID: 10386346 [No Abstract] [Full Text] [Related] [Next] [New Search]